Gary H. Lyman, MD, MPH, FRCP (Edin), Co-Chair, Duke University Medical Center
Anna Falanga, MD, Co-Chair, Ospedali Riuiniti Bergamo, Italy
Daniel Clarke-Pearson, MD, University of North Carolina
Christopher Flowers, MD, MS, Winship Cancer Institute
Charles W. Francis, MD, University of Rochester Medical Center
Leigh Gates, Patient Representative, University of Colorado
Mohammad Jahanzeb, MD, University of Tennessee
Ajay Kakkar, MD, PhD, Barts and The London School of Medicine, Thrombosis Research Institute
Alok A. Khorana, MD, University of Rochester Medical Center
Nicole M. Kuderer, MD, Duke University Medical Center
Mark Levine, MD, PhD, McMaster University
Howard A. Liebman, MD, University of Southern California
David S. Mendelson, MD, Premiere Oncology
Gary Edward Raskob, PhD, University of Oklahoma Health Sciences Center
Paul A. Thodiyil, MD, New York Methodist Hospital
David Trent, MD, PhD, Virginia Cancer Center
aAll members of the Expert Panel complied with ASCO policy on conflicts of interest. For full disclosures of the Panel members, visit www.JCO.ASCOPubs.org.
ASCO has released a new evidence-based clinical practice guideline for venous thromboembolism prophylaxis and treatment, updating the 2007 practice guideline.1 The update is based on a systematic review of literature published from December 2007 to December 2012. An Update Committee reviewed...
The close association between cancer and thrombosis has been recognized now for more than 150 years.1 Not only is it now known that patients with cancer are at substantially increased risk of developing venous thromboembolism, even prior to the diagnosis of cancer, but the association between...